{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:38:56Z","timestamp":1791409136376,"version":"4.3.3"},"reference-count":48,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,7,20]],"date-time":"2004-07-20T00:00:00Z","timestamp":1090281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:\u2002<\/jats:bold>\n                    Neonatal alloimmune thrombocytopenia (NATP) caused by fetomaternal mismatch for human platelet (PLT) alloantigens (HPAs) complicates approximately 1 in 1000 to 1 in 2000 pregnancies and can lead to a serious bleeding diathesis, intracranial hemorrhage, and sometimes death of the fetus or neonate. As a national reference center for NATP investigations, our experience with this entity over a 12\u2010year period was reviewed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>STUDY DESIGN AND METHODS:\u2002<\/jats:bold>\n                    The laboratory records of all cases of suspected NATP referred for evaluation from January 1, 1990, to December 31, 2002, were analyzed. The spectrum of PLT alloantibody specificities identified was compared with an earlier reported series of serologically verified NATP cases.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:\u2002<\/jats:bold>\n                    HPA\u2010specific alloantibodies were identified in 1162 (31%) of 3743 sera of mothers of infants with clinically suspected NATP. Maternal HPA\u20101a (Pl\n                    <jats:sup>A1<\/jats:sup>\n                    ) alloimmunization accounted for the majority (79%) of confirmed NATP cases, with HPA\u20105b (Br\n                    <jats:sup>a<\/jats:sup>\n                    ), HPA\u20103a (Bak\n                    <jats:sup>a<\/jats:sup>\n                    ), and HPA\u20101b (PL\n                    <jats:sup>A2<\/jats:sup>\n                    ) alloantibodies accounting for 9, 2, and 4 percent of cases, respectively. In addition, an increase in the number of cases in which multiple HPA\u2010specific alloantibodies were present in maternal sera was observed during the study period.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:\u2002<\/jats:bold>\n                    Although, as with the earlier series, maternal HPA\u20101a alloimmunization was the dominant cause of NATP, the identification of an increasing number of cases due to alternative HPA polymorphisms suggests that investigation for HPA\u20101 incompatibility alone is no longer sufficient to fully evaluate clinically suspect NATP cases.\n                  <\/jats:p>","DOI":"10.1111\/j.1537-2995.2004.04026.x","type":"journal-article","created":{"date-parts":[[2004,7,20]],"date-time":"2004-07-20T07:58:25Z","timestamp":1090310305000},"page":"1220-1225","source":"Crossref","is-referenced-by-count":221,"title":["Human platelet antigen\u2010specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia"],"prefix":"10.1111","volume":"44","author":[{"given":"Anne","family":"Davoren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Aster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarice G.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.12.4402"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-2712(18)30506-7"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of feto\u2010maternal alloimmunization to the platelet\u2010specific antigen HPA 1a (PLA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson LM","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02567.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1999.00216.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994366"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/blood.V23.2.154.154","article-title":"Isoimmune neonatal thrombocytopenic purpura: clinical and therapeutic considerations","volume":"23","author":"Pearson HA","year":"1964","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2001.tb01293.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91733-9"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0338-4535(85)80007-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1959.tb04032.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00331.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114082"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35295125739.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113250"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.6.1561.1561"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood.V78.9.2276.2276","article-title":"Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele\u2010specific oligonucleotide probes","volume":"78","author":"McFarland JG","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.341195065032.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00176.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.3.684.684"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood.V76.9.1698.1698","article-title":"A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka\u2010platelets lack detectable GPIV (CD36)","volume":"76","author":"Yamamoto N","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01839.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2002.tb05343.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05446.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6661(199609\/10)5:5<281::AID-MFM6>3.0.CO;2-D"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00269.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15254"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6661(199605\/06)5:3<137::AID-MFM8>3.0.CO;2-N"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90559-6"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198811243192103"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1988.tb04697.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70582-3"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39199116901.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1996.tb02542.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/tm.2000.7397"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.9992647.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1996.tb00081.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06374.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb00369.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00533.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1692"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody\u2010specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet specific antibodies","volume":"70","author":"Kiefel V","year":"1987","journal-title":"Blood"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02170.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00354.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1997.d01-72.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.351096026369.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2003.tb03315.x"},{"key":"e_1_2_6_49_2","first-page":"P1155","article-title":"Cell lines expressing recombinant platelet membrane glycoprotein isoforms as tools for the characterization of antibodies against low frequency alloantigens in neonatal alloimmune thrombocytopenia","volume":"1","author":"Kroll H","year":"2003","journal-title":"Thromb Haemost"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2004.04026.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2004.04026.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2004.04026.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:29:28Z","timestamp":1697275768000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2004.04026.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,20]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1537-2995.2004.04026.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2004.04026.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,20]]}}}